| 发明名称 |
Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors |
| 摘要 |
The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors. |
| 申请公布号 |
US2016367663(A1) |
申请公布日期 |
2016.12.22 |
| 申请号 |
US201615189577 |
申请日期 |
2016.06.22 |
| 申请人 |
Janssen Biotech, Inc. |
发明人 |
Doshi Parul;Lokhorst Henk M.;Mutis Tuna |
| 分类号 |
A61K39/395;A61K9/00;A61K38/47;A61K31/497 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a subject having a CD38-positive hematological malignancy, comprising administering to the subject in need thereof an anti-CD38 antibody and a survivin inhibitor for a time sufficient to treat the CD38-positive hematological malignancy. |
| 地址 |
Spring House PA US |
